- ¥3tn
- ¥3tn
- ¥936bn
- 86
- 14
- 92
- 75
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 22.62 | ||
| PEG Ratio (f) | 1.43 | ||
| EPS Growth (f) | 18.84% | ||
| Dividend Yield (f) | 0.85% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.73 | ||
| Price to Tang. Book | 5.85 | ||
| Price to Free Cashflow | 52.3 | ||
| Price to Sales | 3.06 | ||
| EV to EBITDA | 25.24 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.43% | ||
| Return on Equity | 3.3% | ||
| Operating Margin | 5.05% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 755,231 | 730,544 | 750,123 | 881,923 | 936,210 | 1,012,189 | 1,064,534 | 3.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +215.18 | +29.62 | +41.29 | +11.66 | -13.9 | +18.55 | +19.11 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Directors
- Yasuo Takeuchi PRE (64)
- Chikashi Takeda CFO (58)
- Nacho Abia COO (53)
- Akihiro Taguchi CTO (63)
- Stefan Kaufmann CAD (53)
- Koji Ando EXO
- Frank Drewalowski EXO
- Kazutaka Eguchi EXO
- Masahito Goto EXO
- Akira Hasegawa EXO
- Hironobu Kawano EXO
- Tetsuo Kobayashi EXO
- Hideki Kusuda EXO
- Toshihiko Ohkubo EXO
- Shigeto Ohtsuki EXO
- Andre Roggan EXO
- Katsuyuki Saito EXO
- Yoshitake Saito EXO
- Tomohisa Sakurai EXO
- Yoshio Tashiro EXO
- Hidenao Tsuchiya EXO
- Wenlei Yang EXO
- Nobuyuki Koga DRC (65)
- Jimmy Beasley IND (58)
- Sumitaka Fujita IND (78)
- D. Robert Hale IND (36)
- Sachiko Ichikawa IND (54)
- Tetsuo Iwamura IND (70)
- Atsushi Iwasaki IND (63)
- Susumu Kaminaga IND (75)
- Yasumasa Masuda IND (64)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- October 12th, 1919
- Public Since
- May 16th, 1949
- No. of Shareholders
- 55,951
- No. of Employees
- 28,838
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 1,165,815,087
- Address
- 2951, Ishikawa-machi, HACHIOJI-SHI, 192-8507
- Web
- https://www.olympus.co.jp/
- Phone
- +81 426422111
- Auditors
- Ernst & Young ShinNihon LLC
Latest News for 7733
Upcoming Events for 7733
Dividend For 7733.T - 0.0000 JPY
Q2 2025 Olympus Corp Earnings Release
Q3 2025 Olympus Corp Earnings Release
Similar to 7733
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
As of Today at 22:55 UTC, shares in Olympus are trading at ¥2,525. This share price information is delayed by 15 minutes.
Shares in Olympus last closed at ¥2,525 and the price had moved by +22.97% over the past 365 days. In terms of relative price strength the Olympus share price has outperformed the Nikkei 225 Index by +11.74% over the past year.
The overall consensus recommendation for Olympus is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Olympus dividend yield is 0.71% based on the trailing twelve month period.
Last year, Olympus paid a total dividend of ¥18, and it currently has a trailing dividend yield of 0.71%.Looking ahead, shares in Olympus are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2025-06-01.
Olympus are due to go ex-dividend on 2025-03-28 and the next dividend pay date is 2025-06-01. The historic dividend yield on Olympus shares is currently 0.71%.
To buy shares in Olympus you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥2,525, shares in Olympus had a market capitalisation of ¥3tn.
Here are the trading details for Olympus:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 7733
Based on an overall assessment of its quality, value and momentum Olympus is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Olympus is ¥2,820. That is 11.71% above the last closing price of ¥2,525.
Analysts covering Olympus currently have a consensus Earnings Per Share (EPS) forecast of ¥102 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Olympus. Over the past six months, its share price has outperformed the Nikkei 225 Index by +33.14%.
As of the last closing price of ¥2,525, shares in Olympus were trading +7.78% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Olympus PE ratio based on its reported earnings over the past 12 months is 22.62. The shares last closed at ¥2,525.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Olympus' management team is headed by:
- Yasuo Takeuchi - PRE
- Chikashi Takeda - CFO
- Nacho Abia - COO
- Akihiro Taguchi - CTO
- Stefan Kaufmann - CAD
- Koji Ando - EXO
- Frank Drewalowski - EXO
- Kazutaka Eguchi - EXO
- Masahito Goto - EXO
- Akira Hasegawa - EXO
- Hironobu Kawano - EXO
- Tetsuo Kobayashi - EXO
- Hideki Kusuda - EXO
- Toshihiko Ohkubo - EXO
- Shigeto Ohtsuki - EXO
- Andre Roggan - EXO
- Katsuyuki Saito - EXO
- Yoshitake Saito - EXO
- Tomohisa Sakurai - EXO
- Yoshio Tashiro - EXO
- Hidenao Tsuchiya - EXO
- Wenlei Yang - EXO
- Nobuyuki Koga - DRC
- Jimmy Beasley - IND
- Sumitaka Fujita - IND
- D. Robert Hale - IND
- Sachiko Ichikawa - IND
- Tetsuo Iwamura - IND
- Atsushi Iwasaki - IND
- Susumu Kaminaga - IND
- Yasumasa Masuda - IND